Literature DB >> 32061948

Cognitive deficits in methamphetamine addiction: Independent contributions of dependence and intelligence.

Rebecca E Fitzpatrick1, Adam J Rubenis2, Dan I Lubman3, Antonio Verdejo-Garcia4.   

Abstract

BACKGROUND: Methamphetamine's effects on brain function have been associated with cognitive deficits, which have a negative impact on clinical outcomes. However, it remains unclear if cognitive deficits relate to methamphetamine dependence (potentially amenable to abstinence and retraining) or background characteristics, mental health and other drug use. We tested the association between methamphetamine dependence and cognitive performance, while factoring in the impact of background characteristics, depressive symptoms and tobacco, alcohol and cannabis use.
METHOD: The sample comprised 108 treatment-seeking participants who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV TR) criteria for methamphetamine dependence and 50 socio-demographically matched controls. We administered a comprehensive neuropsychological test battery (delay discounting, decision making, disinhibition, episodic and working memory) and examined cognitive deficits in methamphetamine users after taking into account socio-demographic characteristics, tobacco, alcohol and cannabis use, and depressive symptoms.
RESULTS: Hierarchical multiple regression analyses showed that methamphetamine dependence was associated with poorer performance in decision-making and disinhibition over and above other predictors, while IQ better explained performance in episodic and working memory. Although duration of methamphetamine use was linked to disinhibition, other patterns of methamphetamine use (including dose and frequency) were not consistently related to performance.
CONCLUSIONS: Methamphetamine dependence impacts inhibitory control and decision-making, whereas lower IQ associates with memory/working memory deficits among methamphetamine users. Findings suggest the need to target disinhibition and impulsive decision-making as part of methamphetamine dependence treatment, while buffering the impact of IQ on memory systems.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognitive tests; Impulsive action; Impulsive choice; Impulsivity; Methamphetamine use disorder

Mesh:

Substances:

Year:  2020        PMID: 32061948     DOI: 10.1016/j.drugalcdep.2020.107891

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  11 in total

Review 1.  AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Authors:  Sara R Westbrook; Lauren K Carrica; Asia Banks; Joshua M Gulley
Journal:  Pharmacol Biochem Behav       Date:  2020-08-20       Impact factor: 3.533

2.  Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway.

Authors:  Baoyu Shen; Dongxian Zhang; Xiaofeng Zeng; Lina Guan; Genmeng Yang; Liu Liu; Jian Huang; Yuanyuan Li; Shijun Hong; Lihua Li
Journal:  Psychopharmacology (Berl)       Date:  2022-01-08       Impact factor: 4.530

3.  Assessing the mediating role of impulsivity between methamphetamine-induced psychotic disorders and increased gambling severity in methamphetamine-dependent individuals.

Authors:  Huixi Dong; Yidong Shen; Wei Hao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-08-16       Impact factor: 5.760

Review 4.  Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Authors:  Douglas R Miller; Mengfei Bu; Adithya Gopinath; Luis R Martinez; Habibeh Khoshbouei
Journal:  J Pharmacol Exp Ther       Date:  2021-09-17       Impact factor: 4.402

5.  Computational models of exploration and exploitation characterise onset and efficacy of treatment in methamphetamine use disorder.

Authors:  Alex H Robinson; Trevor T-J Chong; Antonio Verdejo-Garcia
Journal:  Addict Biol       Date:  2022-05       Impact factor: 4.093

6.  Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study.

Authors:  Nadine Bernhardt; Johannes Petzold; Cornelius Groß; Anna Scheck; Shakoor Pooseh; René Mayer-Pelinski; Ulrich S Zimmermann; Michael N Smolka; Maximilian Pilhatsch
Journal:  Front Psychiatry       Date:  2020-07-02       Impact factor: 4.157

7.  Training and transfer effects of working memory updating training in male abstinent long-term methamphetamine users.

Authors:  Xin Zhao; Lei Wang; Joseph H R Maes
Journal:  Addict Behav Rep       Date:  2021-10-08

Review 8.  Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail.

Authors:  Hanis Mohammad Hazani; Isa Naina Mohamed; Mustapha Muzaimi; Wael Mohamed; Mohamad Fairuz Yahaya; Seong Lin Teoh; Rashidi Mohamed Pakri Mohamed; Mohd Fadzli Mohamad Isa; Sundus Mansoor Abdulrahman; Ravi Ramadah; Mohammad Rahim Kamaluddin; Jaya Kumar
Journal:  Front Pharmacol       Date:  2022-04-07       Impact factor: 5.988

9.  Protocol for a cluster randomised crossover pilot trial of Goal Management Training+ (GMT+) for methamphetamine use disorder.

Authors:  Alexandra C Anderson; Alex H Robinson; Dan I Lubman; Antonio Verdejo-Garcia
Journal:  Contemp Clin Trials Commun       Date:  2022-08-11

10.  Recovery of superior frontal gyrus cortical thickness and resting-state functional connectivity in abstinent heroin users after 8 months of follow-up.

Authors:  Wenhan Yang; Min Zhang; Fei Tang; Yanyao Du; Li Fan; Jing Luo; Cui Yan; Shicong Wang; Jun Zhang; Kai Yuan; Jun Liu
Journal:  Hum Brain Mapp       Date:  2022-03-24       Impact factor: 5.399

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.